GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (FRA:GU5) » Definitions » Total Assets

Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Total Assets : €10,092 Mil (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Total Assets?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Total Assets for the quarter that ended in Sep. 2024 was €10,092 Mil.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Total Assets Growth Rate was 14.00% per year. During the past 3 years, the average Total Assets Growth Rate was 12.40% per year. During the past 5 years, the average Total Assets Growth Rate was 9.90% per year. During the past 10 years, the average Total Assets Growth Rate was 21.90% per year.

During the past 13 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co's highest 3-Year average Total Assets Growth Rate was 45.30%. The lowest was -12.10%. And the median was 11.55%.

Total Assets is connected with ROA %. Guangzhou Baiyunshan Pharmaceutical Holdings Co's annualized ROA % for the quarter that ended in Sep. 2024 was 3.09%. Total Assets is also linked to Revenue through Asset Turnover. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.23.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Total Assets Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Total Assets Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,300.61 7,511.93 9,186.92 10,110.02 10,092.74

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,546.46 10,092.74 10,054.46 9,984.53 10,091.75

Guangzhou Baiyunshan Pharmaceutical Holdings Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=4710.451+5382.287
=10,093

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=4845.369+5246.384
=10,092

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) Total Assets Explanation

Total Assets is connected with ROA %.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=310.392/( (9984.526+10091.753)/ 2 )
=310.392/10038.1395
=3.09 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=2294.161/( (9984.526+10091.753)/ 2 )
=2294.161/10038.1395
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Total Assets Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Traded in Other Exchanges
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Headlines

No Headlines